Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advate in Previously Untreated Hemophilia A Patients
NCT00157157Phase 3Completed
- Sponsor
- Takeda
- Start
- Apr 2004
- Primary completion
- Sep 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 3 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Takeda. Started Apr 2004; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00157157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157157.